Finally, initial reports of decreased FGF21 receptor and co-receptor expression in the context of obesity have been challenged by additional studies that show no change or even increased expression of these receptors in adipose tissue from human subjects with obesity (212, 213). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.